Faron Pharmaceuticals Oy
LSE:FARN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Faron Pharmaceuticals Oy
LSE:FARN
|
FI |
|
Yankuang Energy Group Co Ltd
F:YZCA
|
CN |
|
N
|
NexGen Holdings Corp
OTC:CETI
|
US |
|
V
|
Vinacomin Mong Duong Coal JSC
VN:MDC
|
VN |
|
Y
|
Yoda Pharmaceuticals Inc
TPEX:7829
|
KY |
|
GDS Global Ltd
SGX:5VP
|
SG |
|
Aker Solutions ASA
OSE:AKSO
|
NO |
|
F
|
Fortune Brands Innovations Inc
DUS:2FB
|
US |
|
Lagardere SA
PAR:MMB
|
FR |
|
J
|
Jiutian Chemical Group Ltd
SGX:C8R
|
SG |
|
S
|
Shougang Century Holdings Ltd
HKEX:103
|
HK |
|
TPG Telecom Ltd
ASX:TPG
|
AU |
|
P
|
People's Insurance Company Group of China Ltd
F:PIR
|
CN |
|
Banco Santander SA
OTC:BCDRF
|
ES |
|
N
|
Newell Brands Inc
XMUN:NWL
|
US |
|
A
|
AB Science SA
F:A8D
|
FR |
|
U
|
United Rentals Inc
F:UR3
|
US |
|
ITV PLC
LSE:ITV
|
UK |
|
L
|
Lakshmi Finance and Industrial Corp Ltd
NSE:LFIC
|
IN |
|
Standard BioTools Inc
NASDAQ:LAB
|
US |
Bankruptcy Probability
Faron Pharmaceuticals Oy's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Faron Pharmaceuticals Oy Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FI |
|
Faron Pharmaceuticals Oy
LSE:FARN
|
72m GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
468.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
219.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
185.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
77.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
85.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Faron Pharmaceuticals Oy's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Faron Pharmaceuticals Oy has total debt of 9.2m EUR. This includes both short-term (0 EUR) and long-term (9.2m EUR) debt.
You can find a full breakdown on its Balance Sheet.